Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Azithromycin and Cefixime Combination Versus Azithromycin Alone for the Out-patient Treatment of Clinically Suspected or Confirmed Uncomplicated Typhoid Fever in South Asia; a Randomised Controlled Trial

NCT04349826 is registered in ClinicalTrials.gov with Oxford University Clinical Research Unit, Vietnam as lead sponsor.

NCT NCT04349826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04349826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Azithromycin and Cefixime Combination Versus Azithromycin Alone for the Out-patient Treatment of Clinically Suspected or Confirmed Uncomplicated Typhoid Fever in South Asia; a Randomised Controlled Trial
Lead sponsor
Oxford University Clinical Research Unit, Vietnam
Phase
Phase 4
Overall status
Completed
Start date
May 23, 2021
Completion date
December 31, 2025
Enrollment
2,150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

typhoid fever